Covered recipient · General Payments record
AL E ASANTE-FACEY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$8,483.48
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,295.00 | 5 |
| Travel and Lodging | $863.57 | 3 |
| Food and Beverage | $188.70 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $3,212.27 | 6 |
| Merck Sharp & Dohme Corporation | $855.00 | 3 |
| Acerta Pharma LLC | $280.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $280.00 | 09/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105549345 | CMS |
| GlaxoSmithKline, LLC. | $360.23 | 06/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116165396 | CMS |
| GlaxoSmithKline, LLC. | $276.64 | 07/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115905808 | CMS |
| GlaxoSmithKline, LLC. | $112.47 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116181971 | CMS |
| GlaxoSmithKline, LLC. | $76.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116431139 | CMS |
| GlaxoSmithKline, LLC. | $226.70 | 09/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116424325 | CMS |
| GlaxoSmithKline, LLC. | $2,160.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116440759 | CMS |
| Merck Sharp & Dohme LLC | $225.00 | 06/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141732735 | CMS |
| Merck Sharp & Dohme LLC | $270.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141732737 | CMS |
| Merck Sharp & Dohme LLC | $360.00 | 08/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141732739 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.